Publikationen in Zusammenarbeit mit Forschern von Indiana University – Purdue University Indianapolis (23)

2024

  1. A preliminary examination of the TOMM2 in a sample of Spanish speakers in the United States

    NeuroRehabilitation, Vol. 55, Núm. 2, pp. 235-242

  2. Attention and processing speed tests: Normative data for Spanish-speaking adults in the United States

    NeuroRehabilitation, Vol. 55, Núm. 2, pp. 169-182

  3. Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomas

    Virchows Archiv, Vol. 484, Núm. 3, pp. 441-449

  4. Executive function tests: Normative data for Spanish-speaking adults in the United States

    NeuroRehabilitation, Vol. 55, Núm. 2, pp. 209-221

  5. Investigating the relationship between specific negative symptoms and metacognitive functioning in psychosis: A systematic review

    Psychology and Psychotherapy: Theory, Research and Practice, Vol. 97, Núm. 2, pp. 191-214

  6. Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts

    npj Parkinson's Disease, Vol. 10, Núm. 1

  7. Normative data for tests of visuo-spatial, visuo-constructional skills, and visual memory for Spanish-speaking adults in the United States

    NeuroRehabilitation, Vol. 55, Núm. 2, pp. 223-233

  8. Normative data for verbal fluency and naming tests in Spanish-speaking adults in the United States

    NeuroRehabilitation, Vol. 55, Núm. 2, pp. 195-208

  9. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study

    Brain, Vol. 147, Núm. 8, pp. 2652-2667

  10. WHO-UCLA auditory verbal learning test: Normative data for Spanish-speaking adults in the United States

    NeuroRehabilitation, Vol. 55, Núm. 2, pp. 183-193

2023

  1. Executive Summary of the Second International Guidelines for the Diagnosis and Management of Pediatric Acute Respiratory Distress Syndrome (PALICC-2)

    Pediatric Critical Care Medicine, Vol. 24, Núm. 2, pp. 143-168

  2. Investigating the relationship between negative symptoms and metacognitive functioning in psychosis: An individual participant data meta-analysis

    Psychology and Psychotherapy: Theory, Research and Practice, Vol. 96, Núm. 4, pp. 918-933

2022

  1. Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort

    npj Parkinson's Disease, Vol. 8, Núm. 1

  2. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Nature genetics, Vol. 54, Núm. 4, pp. 412-436

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study

    The Lancet Neurology, Vol. 19, Núm. 1, pp. 71-80

2019

  1. Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)

    Parkinsonism and Related Disorders, Vol. 62, pp. 201-209

2018

  1. The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

    Annals of Clinical and Translational Neurology, Vol. 5, Núm. 12, pp. 1460-1477

2015

  1. Distinct Neurodegenerative Changes in an Induced Pluripotent Stem Cell Model of Frontotemporal Dementia Linked to Mutant TAU Protein

    Stem Cell Reports, Vol. 5, Núm. 1, pp. 83-96

2014

  1. Michael J. Fox Foundation LRRK2 Consortium: Geographical differences in returning genetic research data to study participants

    Genetics in Medicine